|Place of Origin:||China|
|Model Number:||1.25g, 2.5g|
|Minimum Order Quantity:||100000|
|Packaging Details:||50 vials/box|
|Supply Ability:||500, 000 vials per day|
|Product:||Piperacillin Sodium And Sulbactam Sodium For Injection 4:1||Specification:||1.25g, 2.5g|
|Standard:||BP, USP||Packing:||50 Vials/box|
1.25g 2.5g Dry Powder Piperacillin Sodium / Sulbactam Sodium Injection
Product : Piperacillin Sodium and Sulbactam Sodium for Injection 4:1
Specification : 1.25g, 2.5g
Standard : BP, USP
Packing : 50 vials/box
Piperacillin is a semisynthetic, broad-spectrum, ampicillin derived ureidopenicillin antibiotic proposed for pseudomonas infections. It is also used in combination with other antibiotics.
Sulbactam is a β-lactamase inhibitor given in combination with β-lactam antibiotics to inhibit β-lactamase, an enzyme produced by bacteria that destroys the antibiotics.
For the treatment of polymicrobial infections.
Piperacillin is a penicillin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms. The name "penicillin" can either refer to several variants of penicillin available, or to the group of antibiotics derived from the penicillins. Piperacillin has in vitro activity against gram-positive and gram-negative aerobic and anaerobic bacteria. The bactericidal activity of Piperacillin results from the inhibition of cell wall synthesis and is mediated through Piperacillin binding to penicillin binding proteins (PBPs). Piperacillin is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended spectrum beta-lactamases.
Mechanism of action
By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, Piperacillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that Piperacillin interferes with an autolysin inhibitor.